Cocrystal Pharma, Inc.

Filed a patent for "inhibitors for coronaviruses" on Mon, January 29, 2024

Filed a patent for "peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication" on Thu, May 18, 2023

Filed a patent for "inhibitors of norovirus and coronavirus replication" on Thu, May 25, 2023

Filed a patent for "inhibitors of norovirus and coronavirus replication" on Thu, April 27, 2023

Filed a patent for "polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenza" on Thu, January 18, 2024